Literature DB >> 25542602

An analysis of etiology, causal pathogens, imaging patterns, and treatment of Japanese patients with bronchiectasis.

Toru Kadowaki1, Shuichi Yano2, Kiryo Wakabayashi3, Kanako Kobayashi4, Shigenori Ishikawa5, Masahiro Kimura6, Toshikazu Ikeda7.   

Abstract

BACKGROUND: Bronchiectasis (BE), a syndrome that presents with persistent or recurrent bronchial sepsis related to irreversibly damaged and dilated bronchi, has not been well-characterized in Asians. This study aims to review the etiology, causal pathogens, imaging patterns, and treatment of BE and to define the prognostic factors for acute exacerbation in a Japanese population.
METHODS: We performed a retrospective cohort study of 147 patients (104 women; median age, 73 years; range, 30-95 years) with BE at our institution using high-resolution computed tomography to identify imaging patterns and the area of pulmonary involvement.
RESULTS: Common BE etiologies were idiopathic (N=50 [34%]), sinobronchial syndrome (N=37 [25%]), non-tuberculous mycobacteriosis (NTM; N=26 [18%]), and previous respiratory infection (N=21[14%]). Pseudomonas aeruginosa was the most common causal pathogen (24%). Common imaging patterns were cylindrical (66%) and mixed including cylindrical pattern (47%). The median number of involved lobes was 2; 49% of the patients had ≥ 3 involved lobes, and 49% had middle lobe and left lingula dominant BE. Patients with predominantly lower lobe BE comprised 4% of the NTM group and 48% of the non-NTM group (P<0.001). In multivariate analysis, cystic BE was a predictor for frequent exacerbations in non-NTM patients (OR=7.947; P=0.004) which led to increased hospital admissions (OR=4.691; P=0.004).
CONCLUSIONS: Idiopathic and sinobronchial syndrome were common causes of BE. Etiology did not contribute to imaging pattern or predictors of exacerbations. Cystic BE was a predictor for frequent exacerbations in the non-NTM BE patients.
Copyright © 2014 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bronchiectasis (BE); Cystic bronchiectasis; Etiology; Exacerbation

Mesh:

Year:  2014        PMID: 25542602     DOI: 10.1016/j.resinv.2014.09.004

Source DB:  PubMed          Journal:  Respir Investig        ISSN: 2212-5345


  8 in total

1.  Characteristics and prognosis of microscopic polyangiitis with bronchiectasis.

Authors:  Hiroki Tashiro; Koichiro Takahashi; Masahide Tanaka; Kazutoshi Komiya; Tomomi Nakamura; Shinya Kimura; Yoshifumi Tada; Naoko Sueoka-Aragane
Journal:  J Thorac Dis       Date:  2017-02       Impact factor: 2.895

Review 2.  Suspecting non-cystic fibrosis bronchiectasis: What the busy primary care clinician needs to know.

Authors:  Diego J Maselli; Bravein Amalakuhan; Holly Keyt; Alejandro A Diaz
Journal:  Int J Clin Pract       Date:  2017-02       Impact factor: 2.503

Review 3.  Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis.

Authors:  Ravishankar Chandrasekaran; Micheál Mac Aogáin; James D Chalmers; Stuart J Elborn; Sanjay H Chotirmall
Journal:  BMC Pulm Med       Date:  2018-05-22       Impact factor: 3.317

Review 4.  Why, when and how to investigate primary ciliary dyskinesia in adult patients with bronchiectasis.

Authors:  Martina Contarini; Amelia Shoemark; Jessica Rademacher; Simon Finch; Andrea Gramegna; Michele Gaffuri; Luca Roncoroni; Manuela Seia; Felix C Ringshausen; Tobias Welte; Francesco Blasi; Stefano Aliberti; James D Chalmers
Journal:  Multidiscip Respir Med       Date:  2018-08-09

Review 5.  Bronchiectasis and cough: An old relationship in need of renewed attention.

Authors:  Micheál Mac Aogáin; Sanjay Haresh Chotirmall
Journal:  Pulm Pharmacol Ther       Date:  2019-06-06       Impact factor: 3.410

6.  Morphological features of bronchiectasis in patients with non-tuberculous mycobacteriosis and interstitial pneumonia.

Authors:  Chiori Tabe; Masaki Dobashi; Yoshiko Ishioka; Masamichi Itoga; Hisashi Tanaka; Kageaki Taima; Sadatomo Tasaka
Journal:  BMC Res Notes       Date:  2022-07-26

7.  Global prevalence of non-tuberculous mycobacteria in adults with non-cystic fibrosis bronchiectasis 2006-2021: a systematic review and meta-analysis.

Authors:  Yunchun Zhou; Wei Mu; Jihua Zhang; Shi Wu Wen; Smita Pakhale
Journal:  BMJ Open       Date:  2022-08-01       Impact factor: 3.006

8.  New-onset nontuberculous mycobacterial pulmonary disease in bronchiectasis: tracking the clinical and radiographic changes.

Authors:  Nakwon Kwak; Jong Hyuk Lee; Hyung-Jun Kim; Sung A Kim; Jae-Joon Yim
Journal:  BMC Pulm Med       Date:  2020-11-10       Impact factor: 3.317

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.